Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders. Dalal RS, Gupta S, Goodrick H, Mitri J, et al. Inflamm Bowel Dis 2022;28:146-149.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dalal RS, Gupta S, Goodrick H, Mitri J, et al. Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders. Inflamm Bowel Dis 2022;28:146-149.
PMID: 34245267